deltatrials
Completed PHASE1 INTERVENTIONAL 7-arm NCT03415126

A Study of ASN007 in Patients With Advanced Solid Tumors

A Phase 1, Open-Label, Dose-Finding Study Of ASN007 In Patients With Advanced Solid Tumors

Sponsor: Asana BioSciences

Conditions Cancer Colon Cancer Colon Cancer Liver Metastasis Colonic Neoplasms Malignancy Metastatic Cancer Metastatic Colon Cancer Metastatic Lung Cancer Metastatic Melanoma Metastatic Nonsmall Cell Lung Cancer Metastatic Pancreatic Cancer Neoplasia Neoplasm Neoplasm Metastasis Non Small Cell Lung Cancer Metastatic Pancreas Adenocarcinoma Pancreas Cancer Pancreas Neoplasm Pancreatic Cancer
Interventions ASN007 RD ASN007: ascending doses
Updated 14 times since 2018 Last updated: Jul 7, 2020 Started: Jan 19, 2018 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cancer and Colon Cancer, this trial is completed. The trial is conducted by Asana BioSciences and has accumulated 14 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~Jan 2020 · 3 months · monthly snapshot~Jan 2020 – ~Aug 2020 · 7 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2023 · 25 months · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Mar 2023 — Jul 2024 [monthly]

    Completed PHASE1

  4. Feb 2023 — Mar 2023 [monthly]

    Completed PHASE1

  5. Jan 2021 — Feb 2023 [monthly]

    Completed PHASE1

▶ Show 9 earlier versions

  1. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  2. Jan 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Oct 2019 — Jan 2020 [monthly]

    Recruiting PHASE1

  4. Mar 2019 — Oct 2019 [monthly]

    Recruiting PHASE1

  5. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE1

  6. Nov 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  7. Aug 2018 — Nov 2018 [monthly]

    Recruiting PHASE1

  8. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1

  9. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Asana BioSciences
Data source: Asana BioSciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations